Cargando…
Characterization of Nanodiamond-based anti-HIV drug Delivery to the Brain
Human Immunodeficiency Virus Type 1 (HIV-1) remains one of the leading causes of death worldwide. Present combination antiretroviral therapy has substantially improved HIV-1 related pathology. However, delivery of therapeutic agents to the HIV reservoir organ like Central nervous system (CNS) remain...
Autores principales: | Roy, Upal, Drozd, Vadym, Durygin, Andriy, Rodriguez, Jesse, Barber, Paul, Atluri, Venkata, Liu, Xiaohua, Voss, Thomas G., Saxena, Surendra, Nair, Madhavan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5785470/ https://www.ncbi.nlm.nih.gov/pubmed/29371638 http://dx.doi.org/10.1038/s41598-017-16703-9 |
Ejemplares similares
-
DJ1 expression downregulates in neuroblastoma cells (SK-N-MC) chronically exposed to HIV-1 and cocaine
por: Roy, Upal, et al.
Publicado: (2015) -
Preparation and characterization of anti-HIV nanodrug targeted to microfold cell of gut-associated lymphoid tissue
por: Roy, Upal, et al.
Publicado: (2015) -
Drugs of Abuse in HIV infection and neurotoxicity
por: Hidalgo, Melissa, et al.
Publicado: (2015) -
Natural Products as Anti-HIV Agents and Role in HIV-Associated Neurocognitive Disorders (HAND): A Brief Overview
por: Kurapati, Kesava Rao V., et al.
Publicado: (2016) -
Magnetically guided central nervous system delivery and toxicity evaluation of magneto-electric nanocarriers
por: Kaushik, Ajeet, et al.
Publicado: (2016)